Bohai Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment ...
View PDF | Print View
by: Guest
Total views: 207 Word Count: 762
YANTAI, China, Sep 02, 2010 (BUSINESS WIRE) -- Bohai Pharmaceuticals Group, Inc. (OTCBB/OTCQB: BOPH), a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine (TCM) in China, today announced that the Company will present at the Rodman & Renshaw Annual Global Investment Conference at The Palace Hotel in New York City on Wednesday, September 15, 2010 at 11:40 am Eastern time.
Mr. Gene Hsiao, Bohai's Chief Financial Officer, will discuss the Company's business, strategy, and financial performance. The conference will also include a series of one-on-one meetings with institutional investors. Investors interested in scheduling a meeting with the management team can facilitate a request by contacting the Company through its financial communications firm, Trilogy Capital Partners -- Asia (see contact info below) or alternatively by contacting their Rodman & Renshaw representative directly.
A webcast of the event will be held live and can be heard at www.wsw.com/webcast/rrshq18/boph.
Following the live presentation, an audio and slide archive of the presentation will be available under the "Events and Presentations" page on the "Investors" section of the Company's website at www.bohaipharma.com.
To request a one-on-one meeting or to be added to Bohai Pharmaceuticals' email list, please contact Darren Minton at info@trilogy-capital.com or call 212-521-4405.
About Bohai Pharmaceuticals Group, Inc.
Based in the city of Yantai, Shandong Province, China, Bohai Pharmaceuticals Group, Inc. (OTCBB/OTCQB: BOPH) is engaged in the production, manufacturing and distribution of herbal pharmaceuticals based on Traditional Chinese Medicine in China. Bohai's medicines address common health problems such as rheumatoid arthritis, viral infections, gynecological diseases, cardio vascular issues and respiratory diseases. Bohai's products are sold either by prescription through hospitals or over-the-counter through local pharmacies and retail drug store chains. Bohai has approximately 600 employees, including approximately 300 sales representatives, operating from 20 offices throughout China. Bohai's lead products, Tongbi Capsules and Tablets and Lung Nourishing Cream, are eligible for reimbursement under China's National Medical Insurance Program.
For additional information, please visit Bohai's corporate website: www.bohaipharma.com
Cautionary Note Regarding Forward Looking Statements
This press release, the investor presentation material referred to herein and the statements of representatives of Bohai Pharmaceuticals Group, Inc. (the "Company") related thereto contain, or may contain, among other things, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact included herein are "forward-looking statements," including any other statements of non-historical information. These forward-looking statements are subject to significant known and unknown risks and uncertainties and are often identified by the use of forward-looking terminology such as "projects," "may," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," or similar expressions. All forward-looking statements involve material assumptions, risks and uncertainties, and the expectations contained in such statements may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the factors and risks discussed in the periodic reports that the Company files with the Securities and Exchange Commission (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. The Company undertakes no duty to update these forward-looking statements except as required by law.
SOURCE: Bohai Pharmaceuticals Group, Inc.
"#Bernanke says he feared #Lehman collapse http://bit.ly/cLKmGj"
3:23 p.m. EDT, Sept. 2, 2010 from MarketWatch
"Stocks keep close to home ahead of Friday data http://bit.ly/baqdNL"
2:39 p.m. EDT, Sept. 2, 2010 from MarketWatch
"Follow our ETF Investing blog by John Spence @mktwspence"
1:54 p.m. EDT, Sept. 2, 2010 from MarketWatch
"New column by @dcallaway; Mrs. Watanabe corners global currency market http://bit.ly/dAvFxl"
1:16 p.m. EDT, Sept. 2, 2010 from MarketWatch
"Shoppers show their staying power in August http://bit.ly/bfSPYY"
12:49 p.m. EDT, Sept. 2, 2010 from MarketWatch
Utilities, banks drive European markets higher
European stock markets move higher, adding to payrolls-inspired gains from the previous session.
July's trade balance data may unravel mystery
A fresh set of trade data to be released will be eagerly cross-examined by economists after last month's...
Some strategists rethink European banking shares
Given worries about a double-dip recession and the threat of tighter regulation, it's little surprise that...
New Zealand faces quake aftermath
New Zealand extends a state of emergency following Saturday's earthquake, while insurers attempt to...
Additional information:
Traditional Chinese Medicine Chinese Herbal Medicine Information
Chinese Medicine Full text Prescription profile of potentially
AcuMedic Acupuncture Chinese Medicine Clinic, Courses Shop
TianZi Biodiversity Research Development Centre, China, Thailand
Tao Store
Traditional Chinese Medicine and Endangered Animals Advocacy For
Open Directory Business: Healthcare: Alternative: Acupuncture
Chinese Medicine to Modernise to Win
House of Yin Yang Chinese medicine herbal supplement products
Alternative medicine natural health products health healing
http://www.marketwatch.com/sto...
Related "Medicine":
Rating:
Not yet rated
(votes: 0)
Comments
No comments posted.
Add Comment